Updated:
Aquilo Capital Management
Aquilo Capital Management is a biotech hedge fund founded in 2010 and headquartered in San Francisco, United States. The firm focuses on investing in drug...
Aquilo Capital Management
Aquilo Capital Management is a biotech hedge fund founded in 2010 and headquartered in San Francisco, United States. The firm focuses on investing in drug development companies through a value-oriented investment process. It primarily serves the biotechnology and pharmaceutical sectors with hedged and long-only investments. Aquilo Capital Management applies a value-oriented approach to identify opportunities among drug development companies. The firm operates as a specialized hedge fund targeting the life sciences and pharmaceutical industries. Its investment strategy combines hedged and long-only positions within the biotech sector.
General information
Firm type
Hedge Fund
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, United States
Sector focus
Frequently asked questions
What is Aquilo Capital Management?
Aquilo Capital Management is a biotech hedge fund founded in 2010 and headquartered in San Francisco, United States.
What is the firm's investment focus?
The firm focuses on investing in drug development companies within the biotechnology and pharmaceutical sectors, using hedged and long-only investments.
What investment strategy does Aquilo Capital Management use?
Aquilo Capital Management employs a value-oriented investment process to identify opportunities in drug development companies.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on hedge funds?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: